Ironwood Pharmaceuticals | Les Charges D'Exploitation



Operating Expenses Changement Date
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
Almirall EUR 517.43M 265.53M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amarin USD 58.77M 56.06M 2025-03
Ardelyx USD 108M 12M 2024-12
Astellas Pharma JPY 413.25B 17.48B 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Charles River Laboratories USD 899.8M 9.7M 2025-06
Exact Sciences USD 813.23M 10.44M 2025-06
Halozyme Therapeutics USD 123.28M 48K 2025-06
Incyte USD 904.7M 56.97M 2025-06
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
MacroGenics USD 35.94M 20.58M 2024-12
Moderna USD 1.04B 113M 2025-06
Myriad Genetics USD 224.9M 24.7M 2025-03
Pacira USD 170.87M 3.93M 2025-06
PTC Therapeutics USD 213.73M 7.86M 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Takeda JPY 922.12B 206.21B 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06


Ironwood Pharmaceuticals Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.